IBMX
CAS No. 28822-58-4
IBMX( Isobutylmethylxanthine | 1-Methyl-3-Isobutylxanthine )
Catalog No. M13880 CAS No. 28822-58-4
3-Isobutyl-1-methylxanthine is a potent cyclic nucleotide phosphodiesterase inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 50MG | 42 | In Stock |
|
| 100MG | 52 | In Stock |
|
| 200MG | 95 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameIBMX
-
NoteResearch use only, not for human use.
-
Brief Description3-Isobutyl-1-methylxanthine is a potent cyclic nucleotide phosphodiesterase inhibitor.
-
Description3-Isobutyl-1-methylxanthine is a potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates cyclic nucleotide regulated protein kinases.(In Vitro):IBMX (0.5 mM) induces neural-like cells for neural differentiation of cord blood derived mesenchymal-like stem cells.IBMX induces initiation of the differentiation of programpre-adipocytes.IBMX (500 μM) induces neuronal differentiation of small cell lung cancer.IBMX (100 μM) induces differentiation of 3T3-LI adipocytes.IBMX (500 μM) induces adipose tissue-derived stem cells (ADSC) differentiate into neuron-like cells.
-
In Vitro——
-
In Vivo——
-
SynonymsIsobutylmethylxanthine | 1-Methyl-3-Isobutylxanthine
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE3| PDE4| PDE5
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number28822-58-4
-
Formula Weight222.24
-
Molecular FormulaC10H14N4O2
-
Purity>98% (HPLC)
-
SolubilitySoluble in DMSO
-
SMILESO=C(N1C)N(CC(C)C)C2=C(NC=N2)C1=O
-
Chemical Name3-Isobutyl-1-methylxanthine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jin KS, et al. Food Chem Toxicol. 2014 Jun;68:38-43.
molnova catalog
related products
-
GSK-256066
A potent, selective PDE4 inhibitor with pIC50 of 11.5, 11.3, 11.4, and 11.9 for PDE4B, A, C, and D, respectively.
-
FCPR03
FCPR03 is a selective inhibitor of phosphodiesterase 4 (PDE4) with IC50s of 31 nM, 47 nM, and 60 nM for PDE4B1, PDE4D7, and PDE4 catalytic domain, respectively.
-
BAY 2666605
BAY 2666605 is an orally active inhibitor of PDE3A and PDE3B with IC50s of 87 nM and 50 nM, respectively. BAY 2666605 has anticancer effects.
Cart
sales@molnova.com